Latest News
Cathie Wood loves SpaceX, but her firm sold some of its shares this week.
Via The Motley Fool · October 10, 2026
The data center CPU market looks set to explode.
Via The Motley Fool · October 10, 2026
Brian Armstrong is sticking with his $400,000 Bitcoin target. His direction looks sound, but the 2030 deadline is a stretch.
Via The Motley Fool · October 10, 2026
Broadcom's 36% net margin and dominant AI accelerator position contrast sharply with Intel's foundry turnaround and negative free cash flow.
Via The Motley Fool · October 10, 2026
These consumer staples sell everyday brands that have funded decades of consistent dividends.
Via The Motley Fool · October 10, 2026
FTHF, HECO, and GTEK ETFs use niche strategies in emerging markets, hedged crypto, and smaller tech firms, each gaining 40% or more year to date in 2026.
Via MarketBeat · October 10, 2026
Most investors are looking at something beyond the company's existing EV business.
Via The Motley Fool · October 10, 2026
Diversification is still one of the best strategies for long-term investing.
Via The Motley Fool · October 10, 2026
Vinicius Urias Favarao expanded his direct equity stake by 22%, signaling confidence in the Brazilian bank.
Via The Motley Fool · October 10, 2026
Vanguard's large-cap fund delivered 47% more wealth over five years, but State Street's small-cap strategy offers lower volatility and higher income.
Via The Motley Fool · October 10, 2026
Physical AI is moving from software into machines, but the winners may come from very different layers. See which business models have the strongest growth, monetization, and durability.
Via The Motley Fool · October 10, 2026
How does $19,000 sound?
Via The Motley Fool · October 10, 2026
Microsoft's AI strategy is producing stronger signals, but the payoff test is only beginning. See the numbers that could determine whether its enormous investment creates lasting value.
Via The Motley Fool · October 10, 2026
Broadcom stock has the potential to triple in value in the next five years.
Via The Motley Fool · October 10, 2026
Inventiva, Larimar Therapeutics, and Ascentage Pharma face key drug-development milestones, with analysts assigning Buy ratings and triple-digit upside price targets to all three biotech stocks.
Via MarketBeat · October 10, 2026
State Street's fund charges just 0.08% annually versus iShares' 0.32%, but performance and yield tell a more nuanced story.
Via The Motley Fool · October 10, 2026
Any money invested in Kraft Heinz could have gone to a company offering more revenue growth opportunities.
Via The Motley Fool · October 10, 2026
Accelerating revenue growth has whetted investor appetites.
Via Investor's Business Daily · October 10, 2026
Investing like Warren Buffett is simpler than you might think.
Via The Motley Fool · October 10, 2026
Energy Transfer and Enterprise Products Partners combine a low valuation, a high dividend yield, and a rock-solid growth record.
Via The Motley Fool · October 10, 2026
Microsoft should continue to expand, but will its growth pace compare well to its past?
Via The Motley Fool · October 10, 2026
This growth stock is solving the biggest pain point in the AI data center market.
Via The Motley Fool · October 10, 2026
History says that betting on the overall technology sector is a winning portfolio move.
Via The Motley Fool · October 10, 2026
Schneider Electric will pay about $22.6 billion for PTC at a 42% premium, its largest-ever deal, but SBGSY shares fell 16% as investors weighed integration risks and debt funding.
Via MarketBeat · October 10, 2026
Artificial intelligence is just a fancy computer program, and these six companies are well-positioned to provide the ravenous technology with power.
Via The Motley Fool · October 10, 2026